AFP and hepatocellular carcinoma: Ectopic FX expression promoted GDP-L-fucose biosynthesis and subsequent core-fucosylation of α-fetoprotein (AFP), a Food and Drug Administration (FDA)-approved biomarker for early HCC diagnosis [59].